lipella.com (LIPO): O‘sish sur’atiga tuzatilgan narx-foyda
Lipella Pharmaceuticals narxlarining harakati dori vositalarini qayta yo'naltirish muvaffaqiyati va FDA tasdiqlashlariga bog'liq. GURU.Markets interfeysidagi o'sishga moslashtirilgan P/E ko'rsatkichi ushbu grafikni namoyish etadi, bunda 0.00 metriki ushbu darajani belgilaydi. Qovuq saratoni terapiyasi uchun LP-10 ning ishlab chiqilishi operatsion xatarlarni minimallashtirish maqsadida tadqiqotlarni tashqi CRO pudratchilariga autsorsing qilish strategiyasi bilan to'ldirilgan.
Lipella Pharmaceuticals (LIPO) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning kapitalga nisbati Lipella Pharmaceuticals|LIPO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati lipella.com|LIPO - Kompaniya qarzlari|Qarzning balans kapitallashuviga nisbati Lipella|LIPO - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Lipella Pharmaceuticals|Kritik likvidlik koeffitsiyenti lipella.com
- foyda va bozor koeffitsiyentlari statistikasi:
LIPO - Sof foyda|Kutilayotgan sof foyda Lipella Pharmaceuticals|LIPO - Narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati Lipella Pharma|LIPO - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Lipella|LIPO - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Lipella Pharmaceuticals|LIPO - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi lipella.com|LIPO - Joriy yilda bir aksiya uchun foyda o'sishi|Kelgusi yil uchun bir aksiya uchun sof foydaning o'zgarishi prognozi Lipella Pharmaceuticals
Kompaniyaning fundamental tahlili:Lipella Pharmaceuticals Inc LIPO
PEG koeffitsiyenti aktivlarni qiyosiy tahlil qilish uchun ishlatiladi, chunki u foydaning bozor qiymatini uning o'sish sur'ati bilan bog'laydi va qiymat birdan pastga tushganda aktivning qadrsizlanganligidan dalolat beradi. Lipella Pharmaceuticals (LIPO) kompaniyasidagi boshqaruv resurslarining cheklanganligini hisobga olgan holda, tuzatilgan P/E-o'sish koeffitsiyenti ushbu mikro-kapitallashuvga ega kompaniyaning fundamental salohiyatini chuqur pasayishning spekulyativ xavfidan ajratish imkonini beradi.
Raqobatdosh kompaniyalar
HLN (Haleon PLC) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Kenvue Corp KVUE|Verona Pharma Inc. (VRNA) - O‘sish sur’atiga tuzatilgan narx-foyda|MENS: Narx-foyda va o‘sish multiplikatori|ligand.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|AMRX: PEG multiplikatori|Perrigo Company PLC - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|ALVO (Alvotech Corp) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Liquidia Inc. LQDA|Narxning foydaga va o‘sish sur’atiga nisbati Galapagos NV (GLPG)|ANIP (anipharmaceuticals.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati MannKind MNKD|Amphastar Pharmaceuticals Inc - Narxning foydaga va o‘sish sur’atiga nisbati|Pacira - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati ARS Corp SPRY|Theravance Biopharma (TBPH) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati AQST (aquestive.com)|SCPH (scPharmaceuticals, Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Tectonic TECX|Narxning foydaga va o‘sish sur’atiga nisbati Tonix Pharmaceuticals Inc. (TNXP)|Narxning foydaga va o‘sish sur’atiga nisbati SXTC (sxtchina.com)|Narxning foydaga va o‘sish sur’atiga nisbati Eupraxia Pharmaceuticals Inc. EPRX|bioharvest.com - Narxning foydaga va o‘sish sur’atiga nisbati|eXoZymes - PEG multiplikatori|ORMP - PEG multiplikatori|ENTX (enterabio.com) - Narx-foyda va o‘sish multiplikatori|MindWalk Therapeutics - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati ABVC BioPharma|cumberlandpharma.com - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori QNTM|FGEN (FibroGen Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori TELO (Telomir Pharma)|PEG multiplikatori Rani Therapeutics Holdings RANI|SNYR - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti RLYB (Rallybio Corporation)|lexariabioscience.com (LEXX) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Pulmatrix Inc|PTHL (Pheton Holdings Limited) - PEG multiplikatori|PEG multiplikatori Aptorum|PEG multiplikatori LYRA|Narx-foyda va o‘sish multiplikatori impactbiomedinc.com IBO|PEG multiplikatori TNFA (TNF Pharmaceuticals, Inc.)|cbdMD Inc. (YCBD) - O‘sish sur’atiga tuzatilgan narx-foyda|PRFX: Narx-foyda va o‘sish multiplikatori|CYTO - PEG multiplikatori|OPTN (OptiNose, Inc.) - Narx-foyda va o‘sish multiplikatori|PIRS: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PROC (Procaps) - PEG multiplikatori|Petros Pharmaceuticals Inc (PTPI) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori QLI|Narx-foyda va o‘sish multiplikatori ACELYRIN Inc. SLRN|PEG multiplikatori TFFP (TFF Pharmaceuticals)
